Hylla
Titel och upphov Hepatitis C among drug users in Europe : epidemiology, treatment and prevention
Utgivning, distribution etc. Luxembourg : Publication Office of the European Union
Fysisk beskrivning
Anmärkning: Allmän Literaturverzeichnis: Seite 92-97
Anmärkning: Innehåll Foreword -- Executive summary – Acknowledgements – Introduction -- Chapter 1: Hepatitis C virus infection among people who inject drugs -- Chapter 2: Treatment of hepatitis C virus infection among people who inject drugs -- Chapter 3: Strategies to improve hepatitis C care and to enhance treatment uptake and adherence -- Chapter 4: Hepatitis C prevention among people who inject drugs -- Chapter 5: Antiviral medications for hepatitis C virus infection -- Chapter 6: Scaling up hepatitis C treatment -- Chapter 7: A framework for evaluating scale‑up of hepatitis C virus treatment as prevention for people who inject drugs -- Conclusions
Anmärkning: Innehållsbeskrivning, sammanfattning Hepatitis C among drug users in Europe: epidemiology, treatment and prevention provides a timely contribution to raising awareness of the hepatitis C epidemic in Europe and the opportunities now opening up to tackle this problem decisively. A state-of-the-art review of the epidemiology of hepatitis C virus (HCV) infection in Europe and an overview of the way preventive measures are currently implemented in European countries set the scene. International experts address the treatment of HCV infection among people who inject drugs, with an emphasis on how we encourage uptake and deliver effective outcomes. Implementation issues are also explored, as are the complementary roles of treatment and prevention. The new medicines and treatment regimens driving the transformation in the HCV treatment landscape are reviewed in detail. The challenges of scaling up HCV treatment and successfully involving drug-using patients is explored from different viewpoints, including that of the drug user
Term
Indexterm - Okontrollerad
Personnamn
Institutionsnamn European Monitoring Centre for Drugs and Drug Addiction Herausgebendes Organ isb
ISBN
*00003264nam 122004697a 4500
*00128760
*00520160914153032.0
*008160914s2016 lu a 000 0 eng d
*020 $a9789291689293
*020 $a9291689297
*02852$aTD-XD-16-002-EN-C
*035 $a(OCoLC)ocn958069874
*035 $a(SE-LIBR)19669411
*084 $a44.75 $2bcl
*24500$aHepatitis C among drug users in Europe : $bepidemiology, treatment and prevention / $cEditors: Matthew Hickman (School of Social and Community Medicine, University of Bristol, United Kingdom), Natasha K. Martin (Department of Medicine, University of California, United States and University of Bristol, United Kingdom); EMCDDA project group: Isabelle Giraudon, Lucas Wiessing, Dagmar Hedrich, Eleni Kalamara, Paul Griffiths and Roland Simon
*2603 $aLuxembourg : $bPublication Office of the European Union,$c2016
*26421$aLuxembourg : $bPublication Office of the European Union
*300 $a97 Seiten $bDiagramme
*336 $aText $btxt $2rdacontent
*337 $aohne Hilfsmittel zu benutzen $bn $2rdamedia
*338 $aBand $bnc $2rdacarrier
*500 $aLiteraturverzeichnis: Seite 92-97
*5058 $aForeword -- Executive summary – Acknowledgements – Introduction -- Chapter 1: Hepatitis C virus infection among people who inject drugs -- Chapter 2: Treatment of hepatitis C virus infection among people who inject drugs -- Chapter 3: Strategies to improve hepatitis C care and to enhance treatment uptake and adherence -- Chapter 4: Hepatitis C prevention among people who inject drugs -- Chapter 5: Antiviral medications for hepatitis C virus infection -- Chapter 6: Scaling up hepatitis C treatment -- Chapter 7: A framework for evaluating scale‑up of hepatitis C virus treatment as prevention for people who inject drugs -- Conclusions
*520 $aHepatitis C among drug users in Europe: epidemiology, treatment and prevention provides a timely contribution to raising awareness of the hepatitis C epidemic in Europe and the opportunities now opening up to tackle this problem decisively. A state-of-the-art review of the epidemiology of hepatitis C virus (HCV) infection in Europe and an overview of the way preventive measures are currently implemented in European countries set the scene. International experts address the treatment of HCV infection among people who inject drugs, with an emphasis on how we encourage uptake and deliver effective outcomes. Implementation issues are also explored, as are the complementary roles of treatment and prevention. The new medicines and treatment regimens driving the transformation in the HCV treatment landscape are reviewed in detail. The challenges of scaling up HCV treatment and successfully involving drug-using patients is explored from different viewpoints, including that of the drug user
*650 $aHepatitis C
*650 4$aTherapeutics
*653 $aHepatit C
*653 $aIntravenöst narkotikamissbruk
*653 $aBehandling
*653 $aSubstitutionsbehandling
*7001 $aHickman, Matthew$eHerausgeberIn $4edt $eVerfasserIn $4aut
*7001 $aMartin, Natasha K.$eHerausgeberIn $4edt $eVerfasserIn $4aut
*7001 $aGiraudon, Isabelle$eVerfasserIn $4aut
*7001 $aWiessing, Lucas$eVerfasserIn $4aut
*7001 $aHedrich, Dagmar$eVerfasserIn $4aut
*7001 $aKalamara, Eleni$eVerfasserIn $4aut
*7001 $aGriffiths, Paul$eVerfasserIn $4aut
*7001 $aSimon, Roland$eVerfasserIn $4aut
*7102 $aEuropean Monitoring Centre for Drugs and Drug Addiction$eHerausgebendes Organ $4isb
*830 0$aEMCDDA insights,$x1606-1683 ;$v23
*852 $h5d168
*85641$uhttp://www.emcdda.europa.eu/publications/insights/hepatitis -c-among-drug-users-in-europe_en
^
Det finns inga omdömen till denna titeln.
Klicka här
för att vara den första som skriver ett omdöme.